A groundbreaking bioprinting technology developed by VRIT, a start-up co-founded at the University of Toronto, is transforming wound care by offering a faster, less painful alternative to traditional skin grafts.
The handheld INSITE bioprinter allows surgeons to print personalized bioinks directly onto wounds – promoting rapid healing, reducing complications and minimizing scarring. By combining regenerative medicine with clinical practice, VRIT is advancing a patient-centered approach that tailors treatment to each individual’s biology.
These personalized bioinks not only speed up recovery but also lower infection risks and reduce the need for invasive surgeries – representing a major step forward in tissue engineering and redefining how complex injuries are treated. This innovation holds particular promise for patients with extensive burns, chronic wounds, or those unable to undergo skin graft procedures. With a focus on making advanced wound care more accessible, efficient, and effective, VRIT’s work is reshaping clinical practice and setting new standards in regenerative medicine.
For more information, visit the University of Toronto.
